Drug Profile
Research programme: protein therapeutics - Epistem
Alternative Names: EPI-2221; EPI-288; EPI-3905; EPI-6Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Epistem
- Class Peptides; Proteins; Recombinant proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes - Cancer; Gastrointestinal disorders
Highest Development Phases
- No development reported Cancer; Gastrointestinal disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in United Kingdom
- 16 Jul 2016 No recent reports of development identified for preclinical development in Gastrointestinal-disorders in United Kingdom
- 23 Sep 2010 Research programme: protein therapeutics - Epistem is available for licensing http://www.epistem.co.uk/default.asp